Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

A novel multi-unit tablet for treating circadian rhythm diseases.

Liu Q, Gong Y, Shi Y, Jiang L, Zheng C, Ge L, Liu J, Zhu J.

AAPS PharmSciTech. 2013 Jun;14(2):861-9. doi: 10.1208/s12249-013-9975-8. Epub 2013 May 7.

2.

[Studies on preparation of isosorbide-5-mononitrate pulsatile controlled-release pellets and various influence factors].

Wang R, Huang G, Fang Z.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2008 Aug;25(4):885-8. Chinese.

PMID:
18788301
3.

Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.

Varum FJ, Merchant HA, Goyanes A, Assi P, Zboranová V, Basit AW.

Int J Pharm. 2014 Jul 1;468(1-2):172-7. doi: 10.1016/j.ijpharm.2014.04.019. Epub 2014 Apr 13.

PMID:
24727141
4.

Chitosan and enteric polymer based once daily sustained release tablets of aceclofenac: in vitro and in vivo studies.

Mutalik S, Manoj K, Reddy MS, Kushtagi P, Usha AN, Anju P, Ranjith AK, Udupa N.

AAPS PharmSciTech. 2008;9(2):651-9. doi: 10.1208/s12249-008-9075-3. Epub 2008 May 24.

5.

Dual coating of swellable and rupturable polymers on glipizide loaded MCC pellets for pulsatile delivery: formulation design and in vitro evaluation.

Yadav D, Survase S, Kumar N.

Int J Pharm. 2011 Oct 31;419(1-2):121-30. doi: 10.1016/j.ijpharm.2011.07.026. Epub 2011 Jul 22.

PMID:
21807081
6.

Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.

Sankalia JM, Sankalia MG, Mashru RC.

J Control Release. 2008 Jul 2;129(1):49-58. doi: 10.1016/j.jconrel.2008.03.016. Epub 2008 Mar 26.

PMID:
18456362
7.

Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.

Lin HL, Lin SY, Lin YK, Ho HO, Lo YW, Sheu MT.

Eur J Pharm Biopharm. 2008 Sep;70(1):289-301. doi: 10.1016/j.ejpb.2008.03.021. Epub 2008 Apr 22.

PMID:
18539015
8.

Isosorbide-5-mononitrate (5-ISMN) sustained-release pellets prepared by double layer coating for reducing 5-ISMN migration and sublimation.

Li G, Han D, Guan T, Zhao X, He H, Tang X.

Int J Pharm. 2010 Nov 15;400(1-2):138-44. doi: 10.1016/j.ijpharm.2010.08.046. Epub 2010 Sep 6.

PMID:
20826202
9.

[Preparation and in vitro evaluation of tanshinone IIA pulsatile release pellets].

Liang XD, Zheng Y, Fan TY.

Beijing Da Xue Xue Bao. 2010 Oct 18;42(5):559-64. Chinese.

10.
11.

Sustained-release pellets prepared by combination of wax matrices and double-layer coatings for extremely water-soluble drugs.

Tian L, Zhang Y, Tang X.

Drug Dev Ind Pharm. 2008 Jun;34(6):569-76. doi: 10.1080/03639040701831702 .

PMID:
18568906
12.

Erodible time-dependent colon delivery systems with improved efficiency in delaying the onset of drug release.

Del Curto MD, Palugan L, Foppoli A, Zema L, Gazzaniga A, Maroni A.

J Pharm Sci. 2014 Nov;103(11):3585-3593. doi: 10.1002/jps.24150. Epub 2014 Sep 11.

PMID:
25213173
13.

Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.

Liu Y, Sun Y, Sun J, Zhao N, Sun M, He Z.

Int J Pharm. 2012 Apr 15;426(1-2):21-8. doi: 10.1016/j.ijpharm.2011.12.053. Epub 2012 Jan 14.

PMID:
22266529
14.

Development and release mechanism of diltiazem HCl prolonged release matrix tablets.

Boyapally H, Nukala RK, Douroumis D.

Drug Deliv. 2009 Feb;16(2):67-74. doi: 10.1080/10717540802586220 .

PMID:
19267297
15.

Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.

Ghanam D, Kleinebudde P.

Int J Pharm. 2011 May 16;409(1-2):9-18. doi: 10.1016/j.ijpharm.2011.02.016. Epub 2011 Feb 16.

PMID:
21335073
16.

Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.

Serratoni M, Newton M, Booth S, Clarke A.

Eur J Pharm Biopharm. 2007 Jan;65(1):94-8. Epub 2006 Jul 22.

PMID:
17056237
17.

Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.

Hu LD, Liu Y, Tang X, Zhang Q.

Eur J Pharm Biopharm. 2006 Oct;64(2):185-92. Epub 2006 May 10.

PMID:
16797948
18.
19.

Development of a tamsulosin hydrochloride controlled-release capsule consisting of two different coated pellets.

Zhang X, Tang X, Yang R.

Drug Dev Ind Pharm. 2009 Jan;35(1):26-33. doi: 10.1080/03639040802144203 .

PMID:
18686088
20.

Development and optimization of a novel oral controlled delivery system for tamsulosin hydrochloride using response surface methodology.

Kim MS, Kim JS, You YH, Park HJ, Lee S, Park JS, Woo JS, Hwang SJ.

Int J Pharm. 2007 Aug 16;341(1-2):97-104. Epub 2007 Apr 5.

PMID:
17499949

Supplemental Content

Support Center